• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Here's How to Wrangle JPMorgan, the '800-Pound Gorilla' of Banking

The financial services giant just held its first investor day in three years -- let's open the vault and see what's inside.
By BRAD GINESIN
May 27, 2022 | 01:27 PM EDT
Stocks quotes in this article: JPM

JPMorgan (JPM)  just this week held its first investor day in three years. Despite the 20% decline in the stock this year, CEO Jamie Dimon and his management team were upbeat as they gave calm reassurance that the bank was doing well. Let's dig into the presentation and I'll give my take on how to invest in the financial services giant.

At the investor day, the team's message was clear: JPMorgan is prepared for any economic outcome, global offerings have given the bank a competitive advantage, and JPM is investing in high-return opportunities. As a bastion of stability in an uncertain macro environment, I believe JPM is an ideal candidate to buy -- and to write calls after the stock pullback.

Looking back, we see that the market had overshot with optimism in last year's rally. JPM had spiked too high after the bank's earnings had far outpaced expectations thanks to the release of pandemic-related loan-loss reserves -- which had pumped up the bottom line. Since, the normalization of earnings has proved a disappointment for Wall Street, knocking the stock to about 10-times 2023 expected earnings. Now, there's significant negativity baked into the shares.

At the investor day, net investing income was raised by $3 billion to $56 billion, reflecting the enormous benefit banks reap from a higher interest rate environment. Jamie Dimon also emphasized the firm's growing market share in all categories. Significant investments in technology, up 13% to $14 billion this year, have helped the bank out-duel competition. JPM also expects high single-digit loan growth in 2022.

JPMorgan management prepared Wall Street for slightly higher expenses next year because of compensation inflation. JPM expects to continue to optimize the balance sheet and focus on cash acquisitions, reflected in a relatively small stock buyback program this year. Since 2012, JPM has lowered its shares outstanding from around 3.9 billion to around 2.9 billion through aggressive buybacks that will likely return in future years.

Importantly, management notes that the credit outlook in the U.S. remains strong. Also, by the end of 2022, it expects net investment income to be annualizing at $66 billion. Both reassuring outlooks compelled the Street to raise net investment income estimates and lower credit costs.

"JPM is still the 800-pound gorilla in terms of diversification, balance sheet strength, organic growth momentum, consistency, and profitability, which deserves a premium valuation" says Oppenheimer, as it summed up its takeaway from the investor day. 

A conservative investment strategy is buying JPM stock and writing at-the-money calls against the position. Buying the stock around $130 and writing the November $130 calls, for instance, would return over 9% (plus 18% annualized) including two dividend payments, if the stock closes over $130 upon expiration. Certainly, a lot can change in six months, but a buy/write strategy for the top global bank after a reassuring outlook is a prudent way to capitalize on the reasonable valuation and elevated assumed volatility. 

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Ginesin was long JPM/short JPM calls

TAGS: Earnings | Investing | Stocks | Banking | Financial Services

More from Stocks

Hopeful Investors Get Scraped by the Bear

James "Rev Shark" DePorre
Jun 28, 2022 4:24 PM EDT

Bulls hoped that a bottom had been found, but they overlooked the reasons behind the rally last week.

Bed Bath & Beyond's Weakness is Likely to Persist

Bruce Kamich
Jun 28, 2022 2:36 PM EDT

The shares have been in the single digits since early May.

Let's Look Under the 'Shell' of This ESG-Style Fund

Mark Abssy
Jun 28, 2022 2:00 PM EDT

One of the Nuveen Global Net-Zero Transition exchange-traded fund's largest holdings is Shell, so let's drill down on this supposedly environmentally friendly ETF.

Taking Another Look at ON Semiconductor's Charts

Bruce Kamich
Jun 28, 2022 1:43 PM EDT

Here's what to watch for.

Feeling Queasy Over Moderna's Outlook? Investors May Still Get Their Shot

Brad Ginesin
Jun 28, 2022 12:45 PM EDT

With an expected dip for 2023, the pharmaceutical company could see its mRNA technology win big over the long term -- and investors could be rewarded.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:56 AM EDT STEPHEN GUILFOYLE

    Stocks Under $10

    Check out what's going on in the Stocks Under $10 ...
  • 12:04 AM EDT PAUL PRICE

    Two Good Signs -- Especially for Small-Cap Investors

  • 12:10 AM EDT PAUL PRICE

    More Insider Buying in American Woodmark (AMWD)

    American Woodmark , which I've discussed here fr...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login